Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer

NCT00216021 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Capecitabine
DRUG: Oxaliplatin

Sponsor

Hoosier Cancer Research Network

Collaborators

[object Object]
[object Object]
[object Object]